ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1933 • 2012 ACR/ARHP Annual Meeting

    Incidence and Early Detection of Retinal Toxicity in Patients Treated with Chloroquine and Hydroxichloroquine in Rheumatology Practice

    Sandra Soro Marin1, Ana del Carmen Haro Martínez1, Deseada Palma Sanchez1, María del Rocío Gonzalez Molina1, Marta Mayor Gonzalez2 and Elena Rubio Velazquez3, 1Rheumatology, Rafael Mendez Hospital, Spain., Lorca (Murcia), Spain, 2Rheumatology, Rafael Mendez Hospital, Lorca (Murcia), Spain, 3Ophthalmology, Rafael Mendez Hospital, Lorca (Murcia)

    Background/Purpose: The antimalarial drugs are considered safe and well tolerated, with low risk of side effects. Hydroxychloroquine is considered safer but less effective than chloroquine,…
  • Abstract Number: 1934 • 2012 ACR/ARHP Annual Meeting

    Improvement in Cryoglobulin Detection Employing a Temperature Controlled Sample Transporter

    W. Winn Chatham1, Moon Nahm2 and William H. Benjamin Jr.2, 1University of Alabama at Birmingham, Birmingham, AL, 2Pathology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Optimal conditions for detecting serum cryoglobulins in patients with suspected vasculitis requires drawn blood samples remain at 37 degree F or higher temperature until…
  • Abstract Number: 1935 • 2012 ACR/ARHP Annual Meeting

    Longitudinal Peripheral Blood Lymphocyte Subsets Correlate with Decreased Disease Activity in Juvenile Dermatomyositis

    Floranne C. Ernste1, Cynthia S. Crowson2, Consuelo Lopez de Padilla3, Molly Hein4, Abigail B. Green2 and Ann M. Reed5, 1Division of Rheumatology, Mayo Clinic Rochester, Rochester, MN, 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 3Rheumatology/Immunology Research, Mayo Clinic, Rochester, MN, 4Mayo Clinic, Rochester, MN, 5Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose: Perturbations in peripheral blood lymphocyte (PBL) subsets in juvenile dermatomyositis (JDM) are variably and inconsistently reported in active and inactive disease. Decreased PBL CD8+…
  • Abstract Number: 1936 • 2012 ACR/ARHP Annual Meeting

    The Human Leukocyte Antigen DRB1*13:02-DQB1*06:04-DPB1*04:01 Haplotype Is Closely Associated with Dermatomyositis Patients with Anti-CADM-140 (Melanoma Differentiation-Associated Protein 5: MDA5) Antibody

    Yuji Hosono1, Chikashi Terao2, Ran Nakashima1, Yoshitaka Imura3, Naoichiro Yukawa4, Hajime Yoshifuji1, Motomu Hashimoto5, Koichiro Ohmura6, Takao Fujii7 and Tsuneyo Mimori1, 1Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 2Center for Genomic Medicine, Kyoto University, Kyoto, Japan, 3Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 4Dept of Rheum & Clinical Immun, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 5The Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 6Rheumatology & Clin Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 7Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    Background/Purpose: Recent studies have revealed that anti-CADM-140 (MDA5/IFIH1)-antibody positive dermatomyositis (DM) patients frequently develop acute or subacute progressive interstitial pneumonia (A/SIP) with poor prognosis. However,…
  • Abstract Number: 1937 • 2012 ACR/ARHP Annual Meeting

    HLA-DRB1*0101/*0405 Is Associated with Susceptibility to Anti-MDA5 Antibody-Positive Dermatomyositis in the Japanese Population

    Takahisa Gono1, Yasushi Kawaguchi1, Masataka Kuwana2, Tomoko Sugiura1, Takefumi Furuya1, Kae Takagi1, Hisae Ichida1, Yasuhiro Katsumata1, Masanori Hanaoka1, Yuko Okamoto1, Yuko Ota1, Sayuri Kataoka1 and Hisashi Yamanaka1, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    Background/Purpose: The complication of interstitial lung disease (ILD) is associated with the anti-aminoacyl tRNA synthetase antibody (ARS ab) or the anti-melanoma differentiation-associated gene 5 antibody…
  • Abstract Number: 1938 • 2012 ACR/ARHP Annual Meeting

    A New Enzyme-Linked Immunosorbent Assay System for Detecting Autoantibodies to Aminoacyl-tRNA Synthetases: Clinical Usefulness in Myositis and Interstitial Pneumonia

    Ran Nakashima1, Yoshitaka Imura2, Minae Seto3, Akihiro Murakami3, Yuji Hosono4, Kizuku Watanabe5, Tomohiro Handa5, Michiaki Mishima5, Michito Hirakata6, Tsutomu Takeuchi7, Keishi Fujio8, Kazuhiko Yamamoto9, Hitoshi Kohsaka10, Yoshinari Takasaki11, Noriyuki Enomoto12, Kingo Chida12, Toshihiro Nukiwa13 and Tsuneyo Mimori1, 1Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 2Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan, 3Medical & Biological Laboratories Co., Ltd., Ina, Japan, 4Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan, 5Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan, Kyoto, Japan, 6Internal Medicine, Keio University, Tokyo, Japan, 7Keio University School of Medicine, Tokyo, Japan, 8Department of Allergy and Rheumatology, The University of Tokyo, Tokyo, Japan, 9Department of Allergy & Rheumatology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan, 10Department of Medicine and Rheumatology, Tokyo Medical and Dental University, Tokyo, Japan, 11Division of Rheumatology, Department of Internal Medicine, Juntendo University, Tokyo, Japan, 12Hamamatsu University School of Medicine, Hamamatsu, Japan, 13Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan

    Background/Purpose: Autoantibodies to aminoacyl-tRNA synthetases (ARS) are the most frequent myositis-specific antibodies and they are useful in the diagnosis and management of polymyositis (PM)/ dermatomyositis…
  • Abstract Number: 1899 • 2012 ACR/ARHP Annual Meeting

    Factors Contributing to Non-Publication of Abstracts Presented At the American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting

    Jennifer M.P. Woo1, Daniel Furst2, Deborah K. McCurdy3, Olivia I. Lund4, Rotem Eyal4, Cijin Piao4 and Gil Amarilyo1, 1Pediatrics/Rheumatology, Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA, 2David Geffen School of Medicine, Div of Rheumatology, University of California at Los Angeles, Los Angeles, CA, 3Pediatric Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA, 4David Geffen School of Medicine at UCLA, Los Angeles, CA

    Background/Purpose: The American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Scientific Meeting (ASM) provides a premier forum for the rapid dissemination of novel…
  • Abstract Number: 1900 • 2012 ACR/ARHP Annual Meeting

    Mormed Project: A New 21st Century Web Platform for Multilingual Communication in systemic Lupus Erythematosus and Antiphospholipid Syndrome

    Oier Ateka-Barrutia1, Adriane Rinsche2, Maria Laura Bertolaccini1, Munther A. Khamashta1 and MORMED consortium3, 1Lupus Research Unit, The Rayne Institute, Kings College London School of Medicine, London, United Kingdom, 2Language Technology Center Ltd., Kingston, United Kingdom, 3EU

    Background/Purpose: The internet is used nowadays as the preferred repository where people search for, access and publish information on any topic. However, language barriers prevent…
  • Abstract Number: 1901 • 2012 ACR/ARHP Annual Meeting

    Chronic  Gout. Improvement According to Outcome Meaures in Rheumatology Domains in Daily Clinical Practice

    Janitzia Vazquez-Mellado1, Betsabé Serrano1, Jaime Mendoza2, Sergio Garcia-Mendez1, V.Chantal Hernández1, Virginia Pascual Ramos3, Ruben Burgos-Vargas1 and Marina Rull-Gabayet2, 1Rheumatology, Hospital General de Mexico, Mexico city, Mexico, 2Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 3Dept de Immunología y Reumato, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

    Background/Purpose: OMERACT has proposed domains to evaluate the effect of treatment in patients with acute and chronic gout. Their frequency, time to improve and percentage…
  • Abstract Number: 1902 • 2012 ACR/ARHP Annual Meeting

    What Factors Are Associated with Target Serum Urate Concentrations in Patients with Gout?

    Nicola Dalbeth1, Meaghan House2, Anne Horne2, Keith J. Petrie3, Fiona M. McQueen4 and William Taylor5, 1Medicine, University of Auckland, Auckland, New Zealand, 2Department of Medicine, University of Auckland, Auckland, New Zealand, 3University of Auckland, Auckland, New Zealand, 4Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand, 5University of Otago, Wellington, New Zealand

    Background/Purpose: Long term serum urate (SU) lowering to a target of
  • Abstract Number: 1903 • 2012 ACR/ARHP Annual Meeting

    Oxidation of Urate to Allantoin by Myeloperoxidase in Gout

    Lisa K. Stamp1, Irada Khalilova2, Mei Zhang1, Rufus Turner2 and Anthony Kettle2, 1Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand, 2Pathology, University of Otago, Christchurch, Christchurch, New Zealand

    Background/Purpose : Hyperuricaemia is critical for the development of gout and may play a pivotal role in the pathophysiology of hypertension, metabolic syndrome, and cardiovascular…
  • Abstract Number: 1904 • 2012 ACR/ARHP Annual Meeting

    Patterns of Gout Treatment and Related Outcomes in US Community Rheumatology Practices: the Relation Between Gout Flares, Time in Treatment, Serum Uric Acid Level and Urate Lowering Therapy

    Max I. Hamburger1, John RP Tesser2, John L. Skosey3, Allan H. Morton4 and Karl M. Kilgore5, 1Rheumatology Associates, Melville, NY, 2AZ Arthritis Rheum Assoc, Paradise Valley, AZ, 3Illinois Bone & Joint Institut, Chicago, IL, 4Warren, MI, 5Cetus Group, LLC, Hunt Valley, MD

    Background/Purpose: Study patterns of gout treatment and related outcomes in US community rheumatology practices, specifically the relation between likelihood and severity of gout flares, time…
  • Abstract Number: 1905 • 2012 ACR/ARHP Annual Meeting

    Increase of Thyroid Stimulating Hormone in Patients On Febuxostat Treatment

    Fernando Perez-Ruiz1 and Ana M. Herrero-Beites2, 1Servicio de Reumatologia, Hospital Universitario Cruces, Baracaldo, Spain, 2Physical Medicine Division, Hospital de Gorliz, Gorliz, Spain

    Background/Purpose: to evaluate whether TSH increases during febuxostat treatment and factors that could be implicated.Methods: before starting febuxostat, patients had analysis at baseline and month…
  • Abstract Number: 1906 • 2012 ACR/ARHP Annual Meeting

    Changes in Gout patient´s Clinical Profile in the Last Two Decades

    Fernando Perez-Ruiz1 and Ana M. Herrero-Beites2, 1Servicio de Reumatologia, Hospital Universitario Cruces, Baracaldo, Spain, 2Physical Medicine Division, Hospital de Gorliz, Gorliz, Spain

    Background/Purpose: to assess whether changes in the clinical profile of gout are observed in a large cohort of gout patients over the last 20 years.…
  • Abstract Number: 1907 • 2012 ACR/ARHP Annual Meeting

    Pharmacological Management of Gout in Italy in the Years 2005-2009: A Nationwide, Population-Based Study

    Lorenzo Cavagna1, Gianluca Trifirò2, Roberto Caporali3, P. Morabito2, C. Ferrajolo4, S. Pecchioli5, M. Simonetti5, G. Medea6, C. Cricelli7, A. Caputi2, G. Mazzaglia5 and Carlomaurizio Montecucco8, 1Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy, 2Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Italy, 3Division of Rheumatology, IRCCSPoliclinico S. Matteo Foundation, Pavia, Italy, 4Department of Experimental Medicine, Pharmacology Section, Second University of Naples, Naples, Italy, 5Health Search, Italian College of General Practitioners, Italy, 6Italian college of General Practitioner, Italy, 7Italian college of General Practitioner, Pavia (italy), Italy, 8Division of Rheumatology, University of Pavia School of Medicine, IRCCS Policlinico San Matteo Foundation, Pavia, Italy

    Background/Purpose:   Despite the increasing interest on gout, only few nationwide drug utilization studies have been conducted on this topic. The aim of this study…
  • « Previous Page
  • 1
  • …
  • 2292
  • 2293
  • 2294
  • 2295
  • 2296
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology